<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is associated with lifestyle factors that affect insulin/IGF signaling, of which the insulin receptor substrate 1 (IRS1) is a key transducer </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated expression, localization and pathologic correlations of IRS1 in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-uninvolved colonic epithelium, primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> with paired <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and in vitro polarizing Caco2 and HT29 cells </plain></SENT>
<SENT sid="2" pm="."><plain>IRS1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein resulted higher, relative to paired mucosa, in <z:mpath ids='MPATH_270'>adenomas</z:mpath> of <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e> patients and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> that overexpressed c-MYC, ß-catenin, InsRß, and IGF1R </plain></SENT>
<SENT sid="3" pm="."><plain>Analysis of IRS1 immunostaining in 24 cases of primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> with paired colonic epithelium and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastasis</z:e> showed that staining intensity was significantly higher in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> relative to both primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (P&lt;0.01) and colonic epithelium (P&lt;0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>Primary and metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, compared to colonic epithelium, contained significantly higher numbers of IRS1-positive cells (P = 0.013 and P = 0.014, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>Pathologic correlations in 163 primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> revealed that diffuse IRS1 staining was associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> combining differentiated phenotype and aggressive markers (high Ki67, p53, and ß-catenin) </plain></SENT>
<SENT sid="6" pm="."><plain>In Caco 2 IRS1 and InsR were maximally expressed after polarization, while IGF1R was highest in pre-polarized cells </plain></SENT>
<SENT sid="7" pm="."><plain>No nuclear IRS1 was detected, while, with polarization, phosphorylated IRS1 (pIRS1) shifted from the lateral to the apical plasma membrane and was expressed in surface cells only </plain></SENT>
<SENT sid="8" pm="."><plain>In HT29, that carry mutations constitutively activating survival signaling, IRS1 and IGF1R decreased with polarization, while pIRS1 localized in nuclear spots throughout the course </plain></SENT>
<SENT sid="9" pm="."><plain>Overall, these data provide evidence that IRS1 is modulated according to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> differentiation, and support a role of IRS1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression and liver metastatization </plain></SENT>
</text></document>